drugset / Trial / NCT04940559

Study of Different Forms of Danicopan (Tablet, Softgel Capsule, Liquid-filled Capsule) in Healthy Participants

NCT04940559

RandomizedCrossoverOpen-labelBasic science

Summary

This was a randomized, crossover, open-label study to assess the relative bioavailability, pharmacokinetics (PK), and safety of three different formulations of danicopan (tablet, softgel capsule, liquid-filled capsule \[LFC\]) in healthy participants.

Timeline

Start
2016-08-02
Primary completion
2016-10-05
Completion
2016-10-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Danicopan Small molecule Oral

Indications

No indication recorded.